Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis
Marjan Gharagozloo, Matthew D. Smith, Elias S. Sotirchos, Jing Jin, Keya Meyers, Michelle Taylor, Thomas Garton, Riley N. Bannon, Hannah‐Noelle Lord, Ted M. Dawson, Valina L. Dawson, Seulki Lee, Peter A. Calabresi
Topics & Concepts
Experimental autoimmune encephalomyelitisNeuroprotectionNeurodegenerationMultiple sclerosisMedicineAgonistMyelin oligodendrocyte glycoproteinEncephalomyelitisInflammationImmunologyNeuroscienceReceptorPharmacologyBiologyInternal medicineDiseaseAdenosine and Purinergic SignalingNeuroinflammation and Neurodegeneration MechanismsCalcium signaling and nucleotide metabolism